Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · IEX Real-Time Price · USD
2.440
+0.330 (15.64%)
Apr 5, 2024, 3:59 PM EDT - Market open
Indaptus Therapeutics Market Cap
Indaptus Therapeutics has a market cap or net worth of $18.27 million as of April 30, 2024. Its market cap has decreased by -23.86% in one year.
Market Cap
18.27M
Enterprise Value
4.93M
1-Year Change
-23.86%
Ranking
Category
Stock Price
$2.44
Market Cap Chart
Since August 4, 2015, Indaptus Therapeutics's market cap has decreased from $60.70M to $18.27M, a decrease of -69.90%. That is a compound annual growth rate of -12.83%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 29, 2024 | 18.10M | 0.56% |
Apr 26, 2024 | 18.00M | -3.23% |
Apr 25, 2024 | 18.60M | -7.46% |
Apr 24, 2024 | 20.10M | -5.63% |
Apr 23, 2024 | 21.30M | 2.40% |
Apr 22, 2024 | 20.80M | 2.97% |
Apr 19, 2024 | 20.20M | -6.05% |
Apr 18, 2024 | 21.50M | -5.29% |
Apr 17, 2024 | 22.70M | -4.62% |
Apr 16, 2024 | 23.80M | 6.73% |
Apr 15, 2024 | 22.30M | -5.91% |
Apr 12, 2024 | 23.70M | 0.85% |
Apr 11, 2024 | 23.50M | 9.30% |
Apr 10, 2024 | 21.50M | 2.38% |
Apr 9, 2024 | 21.00M | 2.94% |
Apr 8, 2024 | 20.40M | -1.92% |
Apr 5, 2024 | 20.80M | 8.33% |
Apr 4, 2024 | 19.20M | - |
Apr 3, 2024 | 19.20M | -4.00% |
Apr 2, 2024 | 20.00M | 2.04% |
Apr 1, 2024 | 19.60M | 2.62% |
Mar 28, 2024 | 19.10M | -10.33% |
Mar 27, 2024 | 21.30M | -10.88% |
Mar 26, 2024 | 23.90M | 12.74% |
Mar 25, 2024 | 21.20M | 7.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Aptose Biosciences | 19.18M |
Galecto | 19.11M |
Streamline Health Solutions | 18.88M |
Akso Health Group | 18.26M |
STRATA Skin Sciences | 18.04M |
ATI Physical Therapy | 17.98M |
Mainz Biomed B.V. | 17.91M |
Benitec Biopharma | 17.89M |